Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
& so far without the NY size buyers!
What do you reckon Hurst? Sprinkles on the doughnuts today?
His patients will be celebrating without a doubt. That one STS patient with significant tumour reduction (in response to the drug) will be followed by others as we speak.
One STS patient has seen significant reduction in tumour in response to AVA6000, with FURTHER SIGNS OF ACTIVITY OBSERVED IN PATIENTS WITH CANCERS NOT LIMITED TO STS
I wouldn’t want to risk being out by trading this share. Next RNS news from FDA?
This seems like it might be on the verge of FDA fast track approval for STS?
So pleased with my top up yesterday 😁
What a delight Sujood you got your RNS this week!
Yep, good old Tesco hiking their prices - Superdrug and Amazon both have it on sale for just under a tenner! (Next day delivery! 😂 🚚).
Trader90 good spot but what price a woman’s dignity? Peeing on a stick seems medieval and degrading given that there’s an alternative.
What we need is the NHS and of private hospitals to offer this alternative.
Thanks Hurst always a enjoyable post!
Doubt it will stay below 11p for long particularly as I’ve got my top up order in and it’s not been filled yet 🤔
Yep Energyshares that was about 57 minutes or so in https://www.youtube.com/watch?v=DlHRRmycxTY
( curtesy of DTW )
DTW j did realise that - just as I don’t think you are the real Trumps wig 😂 or even one of them! I was replying in the same vein much as people reply about Alan. Anyhow I didn’t realise the origin of the death spiral reference so thanks for that 👍🏻
Volume down so not so much a death spiral Tim more likely a slight cooling off as they are just getting on with it! (The transformative RNS). GLALTH
Excellent RNS
Good to see the per ton costs and price per ton in this mornings operational update.
Looks like you were right about them holding back the results Penstock - Bens Creek expects to announce its full year results for the year to 31 March 2023 on Wednesday, 27 September 2023.
Bella, It’s something the company has already mentioned - see - https://avacta.com/wp-content/uploads/2023/06/Avacta-AGM-2023-presentations.pdf
My personal opinion is they either have or they’ve decided to go with the biologically effective dose. Could be a 50% chance they have? 😉
Well spotted LiveLongnProsper 👍
Timstar it states the amended protocol is to be based on evaluation of Phase 1a data. But that can only happen and the decision made of the exact design of Phase 1b when the data has been reviewed. Including a direct comparison of straight dox will be very useful in demonstrating the benefits of AVA6000. So the company may well be still finalising the details?
The study brief states “Phase 1b (Dose Expansion): The dose-expansion phase will comprise 1 to 3 expansion arms in specific tumour types to evaluate the safety and tolerability of AVA6000 at the MTD or RP2D when administered as monotherapy. The tumour types to be explored in Phase 1b, will be determined based on evaluation of the Phase 1a data and the protocol will be amended accordingly”.
Based on the little or no dose limiting side effects could we see the study being widened? Headline “cure for cancer?” 🤔